On the contrary, CYTlow androgen receptor (AR) and estrogen receptor (ER)-positive breast cancer patients were associated with low infiltration and CD8+ T cells and lower overall anticancer immunity and survival [123]. Here, CD8A is linked to breast carcinoma.